ES2157731B1 - ORAL PHARMACEUTICAL PREPARATION OF AN ANTIFUNGIC ACTIVITY COMPOUND AND PROCEDURE FOR PREPARATION. - Google Patents
ORAL PHARMACEUTICAL PREPARATION OF AN ANTIFUNGIC ACTIVITY COMPOUND AND PROCEDURE FOR PREPARATION.Info
- Publication number
- ES2157731B1 ES2157731B1 ES009801539A ES9801539A ES2157731B1 ES 2157731 B1 ES2157731 B1 ES 2157731B1 ES 009801539 A ES009801539 A ES 009801539A ES 9801539 A ES9801539 A ES 9801539A ES 2157731 B1 ES2157731 B1 ES 2157731B1
- Authority
- ES
- Spain
- Prior art keywords
- preparation
- coating
- procedure
- compound
- oral pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 239000008183 oral pharmaceutical preparation Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 230000001716 anti-fugal effect Effects 0.000 title 1
- 239000011248 coating agent Substances 0.000 abstract 5
- 238000000576 coating method Methods 0.000 abstract 5
- 230000000843 anti-fungal effect Effects 0.000 abstract 3
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 2
- 239000002736 nonionic surfactant Substances 0.000 abstract 2
- 239000002356 single layer Substances 0.000 abstract 2
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 239000003429 antifungal agent Substances 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 238000002663 nebulization Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Abstract
Preparación farmacéutica oral de un compuesto de actividad antifúngica y procedimiento para su preparación. Comprende un compuesto de actividad antifúngica como principio activo, un núcleo inerte y un recubrimiento que incluye dicho principio activo, y se caracteriza por el hecho de que dicho núcleo inerte presenta un tamaño de partícula comprendido entre 50-600 {mi}m, y por el hecho de que dicho recubrimiento comprende una única capa que se obtiene por nebulización, sobre dicho núcleo inerte, de una solución que comprende un compuesto de actividad antifúngica, un polímero hidrofílico y un agente tensioactivo no iónico. El procedimiento se lleva a cabo mediante un recubrimiento que comprende una única capa de los núcleos inertes de tamaño entre 50 y 600 {mi}m por nebulización de una solución compuesta por el agente antifúngico, el polímero hidrofílico y el agente tensioactivo no iónico a una velocidad de recubrimiento constante durante todo el proceso; y un solo secado de dicho recubrimiento en el mismo equipo.Oral pharmaceutical preparation of a compound of antifungal activity and procedure for its preparation. It comprises a compound of antifungal activity as an active principle, an inert core and a coating that includes said active principle, and is characterized by the fact that said inert core has a particle size between 50-600 m, and by the fact that said coating comprises a single layer which is obtained by nebulizing, on said inert core, a solution comprising a compound of antifungal activity, a hydrophilic polymer and a non-ionic surfactant. The process is carried out by means of a coating comprising a single layer of the inert nuclei of size between 50 and 600 µm by nebulization of a solution composed of the antifungal agent, the hydrophilic polymer and the non-ionic surfactant at a constant coating speed throughout the process; and a single drying of said coating in the same equipment.
Priority Applications (33)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009801539A ES2157731B1 (en) | 1998-07-21 | 1998-07-21 | ORAL PHARMACEUTICAL PREPARATION OF AN ANTIFUNGIC ACTIVITY COMPOUND AND PROCEDURE FOR PREPARATION. |
PT99931261T PT1103252E (en) | 1998-07-21 | 1999-07-20 | ORAL PHARMACEUTICAL PREPARATION OF A COMPOUND WITH ANTIFUNGAL ACTIVITY AND ITS PREPARATION METHOD |
IL14091099A IL140910A (en) | 1998-07-21 | 1999-07-20 | Oral pharmaceutical composition of a compound having antifungal activity and a method for its preparation |
HU0103708A HU228895B1 (en) | 1998-07-21 | 1999-07-20 | Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
KR1020017000783A KR100572135B1 (en) | 1998-07-21 | 1999-07-20 | Oral medicaments for compounds with antifungal activity and preparation methods thereof |
EEP200100041A EE04415B1 (en) | 1998-07-21 | 1999-07-20 | A pharmaceutical oral preparation of a compound having antimycotic activity and a process for its preparation |
EP99931261A EP1103252B1 (en) | 1998-07-21 | 1999-07-20 | Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
SI9930282T SI1103252T1 (en) | 1998-07-21 | 1999-07-20 | Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
SK86-2001A SK283279B6 (en) | 1998-07-21 | 1999-07-20 | Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
DK99931261T DK1103252T3 (en) | 1998-07-21 | 1999-07-20 | Oral pharmaceutical composition of a compound having a sponge activity and process for its preparation |
MXPA01000681A MXPA01000681A (en) | 1998-07-21 | 1999-07-20 | Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method. |
YUP-39/01A RS50063B (en) | 1998-07-21 | 1999-07-20 | Pharmaceutical oral preparation of a compound having an antifungici activity, and preparation method |
PCT/ES1999/000230 WO2000004881A1 (en) | 1998-07-21 | 1999-07-20 | Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
US09/744,322 US6737082B1 (en) | 1998-07-21 | 1999-07-20 | Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
CZ2001175A CZ291938B6 (en) | 1998-07-21 | 1999-07-20 | Pharmaceutical preparation of antifungal active compound for oral administration and process for preparing thereof |
BR9912300-2A BR9912300A (en) | 1998-07-21 | 1999-07-20 | Oral pharmaceutical composition of a compound having antifungal activity and method for its preparation |
RU2001104894/14A RU2209628C2 (en) | 1998-07-21 | 1999-07-20 | Oral pharmaceutical composition based on antifungal compound and method for its preparing |
PL99345625A PL194740B1 (en) | 1998-07-21 | 1999-07-20 | Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
ES99931261T ES2194480T3 (en) | 1998-07-21 | 1999-07-20 | ORAL PHARMACEUTICAL PREPARATION OF AN ANTIFUNGIC ACTIVITY COMPOUND AND PROCEDURE FOR PREPARATION. |
CA002337509A CA2337509C (en) | 1998-07-21 | 1999-07-20 | Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
DE69905905T DE69905905T2 (en) | 1998-07-21 | 1999-07-20 | ORAL PHARMACEUTICAL COMPOSITION CONTAINING AN ACTIVE SUBSTANCE WITH ANTIMYCOTIC EFFECT AND METHOD FOR THE PRODUCTION THEREOF |
TR2001/00177T TR200100177T2 (en) | 1998-07-21 | 1999-07-20 | Oral pharmaceutical composition of a composition with antifungal activity and method of preparation of this composition. |
NZ509886A NZ509886A (en) | 1998-07-21 | 1999-07-20 | Pharmaceutical oral preparation of either itraconazole or saperconazole having antifungic activity |
UA2001021260A UA64009C2 (en) | 1998-07-21 | 1999-07-20 | Pharmaceutical composition comprising antifungal agent and method for its production |
AT99931261T ATE234077T1 (en) | 1998-07-21 | 1999-07-20 | ORAL PHARMACEUTICAL COMPOSITION CONTAINING AN ACTIVE SUBSTANCE WITH ANTIFUNGAL ACTION AND METHOD FOR THE PRODUCTION THEREOF |
MEP-267/08A MEP26708A (en) | 1998-07-21 | 1999-07-20 | Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
AU47821/99A AU750730B2 (en) | 1998-07-21 | 1999-07-20 | Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
JP2000560874A JP4190732B2 (en) | 1998-07-21 | 1999-07-20 | Oral pharmaceutical composition containing antifungal active compound and process for producing the same |
NO20010289A NO320054B1 (en) | 1998-07-21 | 2001-01-17 | Oral pharmaceutical composition having a compound having antifungal activity and a method for its preparation |
ZA200101293A ZA200101293B (en) | 1998-07-21 | 2001-02-15 | Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method. |
BG105282A BG65187B1 (en) | 1998-07-21 | 2001-02-21 | Pharmaceutical oral use preparation containing compounds with antifungicide effect, and method for preparation thereof |
HR20010128A HRP20010128B1 (en) | 1998-07-21 | 2001-02-21 | Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
HK01108330A HK1037531A1 (en) | 1998-07-21 | 2001-11-27 | Pharmaceutical oral preparation of a compound having an antifungic acitivity, and preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009801539A ES2157731B1 (en) | 1998-07-21 | 1998-07-21 | ORAL PHARMACEUTICAL PREPARATION OF AN ANTIFUNGIC ACTIVITY COMPOUND AND PROCEDURE FOR PREPARATION. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2157731A1 ES2157731A1 (en) | 2001-08-16 |
ES2157731B1 true ES2157731B1 (en) | 2002-05-01 |
Family
ID=8304581
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES009801539A Expired - Fee Related ES2157731B1 (en) | 1998-07-21 | 1998-07-21 | ORAL PHARMACEUTICAL PREPARATION OF AN ANTIFUNGIC ACTIVITY COMPOUND AND PROCEDURE FOR PREPARATION. |
ES99931261T Expired - Lifetime ES2194480T3 (en) | 1998-07-21 | 1999-07-20 | ORAL PHARMACEUTICAL PREPARATION OF AN ANTIFUNGIC ACTIVITY COMPOUND AND PROCEDURE FOR PREPARATION. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES99931261T Expired - Lifetime ES2194480T3 (en) | 1998-07-21 | 1999-07-20 | ORAL PHARMACEUTICAL PREPARATION OF AN ANTIFUNGIC ACTIVITY COMPOUND AND PROCEDURE FOR PREPARATION. |
Country Status (31)
Country | Link |
---|---|
US (1) | US6737082B1 (en) |
EP (1) | EP1103252B1 (en) |
JP (1) | JP4190732B2 (en) |
KR (1) | KR100572135B1 (en) |
AT (1) | ATE234077T1 (en) |
AU (1) | AU750730B2 (en) |
BG (1) | BG65187B1 (en) |
BR (1) | BR9912300A (en) |
CA (1) | CA2337509C (en) |
CZ (1) | CZ291938B6 (en) |
DE (1) | DE69905905T2 (en) |
DK (1) | DK1103252T3 (en) |
EE (1) | EE04415B1 (en) |
ES (2) | ES2157731B1 (en) |
HK (1) | HK1037531A1 (en) |
HR (1) | HRP20010128B1 (en) |
HU (1) | HU228895B1 (en) |
IL (1) | IL140910A (en) |
ME (1) | MEP26708A (en) |
MX (1) | MXPA01000681A (en) |
NO (1) | NO320054B1 (en) |
NZ (1) | NZ509886A (en) |
PL (1) | PL194740B1 (en) |
PT (1) | PT1103252E (en) |
RS (1) | RS50063B (en) |
RU (1) | RU2209628C2 (en) |
SK (1) | SK283279B6 (en) |
TR (1) | TR200100177T2 (en) |
UA (1) | UA64009C2 (en) |
WO (1) | WO2000004881A1 (en) |
ZA (1) | ZA200101293B (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997027764A1 (en) * | 1996-01-31 | 1997-08-07 | South Alabama Medical Science Foundation | Food and vitamin preparations containing the natural isomer of reduced folates |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
EE200200357A (en) | 1999-12-23 | 2003-10-15 | Pfizer Products Inc. | Pharmaceutical compositions providing increased concentrations of the drug substance |
FR2842736B1 (en) | 2002-07-26 | 2005-07-22 | Flamel Tech Sa | ORAL PHARMACEUTICAL FORMULATION IN THE FORM OF A PLURALITY OF MICROCAPSULES FOR PROLONGED RELEASE OF LOW SOLUBLE ACTIVE (S) PRINCIPLE (S) |
US20040115287A1 (en) * | 2002-12-17 | 2004-06-17 | Lipocine, Inc. | Hydrophobic active agent compositions and methods |
ATE357234T1 (en) * | 2003-01-14 | 2007-04-15 | Cimex Pharma Ag | COMPOSITION IN THE FORM OF A SOLID DISPERSION CONTAINING ITRACONAZOLE AND A HYDROPHILIC POLYMER WITH IMPROVED BIOAVAILABILITY |
SI1438961T2 (en) * | 2003-01-14 | 2014-12-31 | Cimex Pharma Ag | Bioequivalent composition of itraconazole dispersed in a hydrophilic polymer |
FR2852607B1 (en) * | 2003-03-20 | 2006-07-14 | PROCESS FOR PRODUCING SMALL SIZE SUGAR MICROSPHERES, MICROSPHERES THAT MAY BE OBTAINED BY THIS PROCESS AND THEIR APPLICATIONS | |
FR2857591B1 (en) * | 2003-07-17 | 2007-11-02 | Ethypharm Sa | PARTICLES COMPRISING AN ACTIVE INGREDIENT IN THE FORM OF CO-PRECIPITATE |
BRPI0412734A (en) * | 2003-07-17 | 2006-09-26 | Tibotec Pharm Ltd | process for preparing particles containing an antiviral |
FR2883179B1 (en) | 2005-03-18 | 2009-04-17 | Ethypharm Sa | COATED TABLET |
JP5435946B2 (en) | 2005-08-22 | 2014-03-05 | ジョンズ ホプキンス ユニバーシティ | Hedgehog pathway antagonists for treating diseases |
CN101283984B (en) * | 2007-04-12 | 2010-05-26 | 永胜药品工业股份有限公司 | Core particle object coated by fungicide and polymer with high biological usage |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
JP2013521249A (en) * | 2010-03-05 | 2013-06-10 | ビーエーエスエフ ソシエタス・ヨーロピア | Pharmaceutical form coated with melt |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
WO2016033556A1 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS |
WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
MA40982A (en) * | 2014-11-19 | 2017-09-26 | Biogen Ma Inc | PHARMACEUTICAL BALL FORMULATION INCLUDING DIMETHYL FUMARATE |
CA2987177A1 (en) * | 2015-05-25 | 2016-12-01 | Sun Pharmaceutical Industries Limited | Once-daily oral pharmaceutical composition of isotretinoin |
CA3033065A1 (en) | 2016-08-11 | 2018-02-15 | Adamis Pharmaceuticals Corporation | Drug compositions |
US20180147215A1 (en) | 2016-11-28 | 2018-05-31 | Lipocine Inc. | Oral testosterone undecanoate therapy |
WO2019113493A1 (en) | 2017-12-08 | 2019-06-13 | Adamis Pharmaceuticals Corporation | Drug compositions |
WO2019208801A1 (en) * | 2018-04-27 | 2019-10-31 | 凸版印刷株式会社 | Sustained-release composite particles, method for producing sustained-release composite particles, dry powder, and wallpaper |
WO2023118082A1 (en) * | 2021-12-22 | 2023-06-29 | Palau Pharma, S.L.U. | Multiparticulate albaconazole composition |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4267179A (en) * | 1978-06-23 | 1981-05-12 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
US4916134A (en) * | 1987-03-25 | 1990-04-10 | Janssen Pharmacuetica N.V. | 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones |
IE61651B1 (en) * | 1990-07-04 | 1994-11-16 | Zambon Spa | Programmed release oral solid pharmaceutical dosage form |
PH30929A (en) * | 1992-09-03 | 1997-12-23 | Janssen Pharmaceutica Nv | Beads having a core coated with an antifungal and a polymer. |
US5567441A (en) * | 1995-03-24 | 1996-10-22 | Andrx Pharmaceuticals Inc. | Diltiazem controlled release formulation |
AU722101B2 (en) * | 1996-05-20 | 2000-07-20 | Janssen Pharmaceutica N.V. | Antifungal compositions with improved bioavailability |
AU719109B2 (en) * | 1996-05-24 | 2000-05-04 | Merck Sharp & Dohme Corp. | Antifungal composition with enhanced bioavailability |
PL330864A1 (en) * | 1996-06-28 | 1999-06-07 | Schering Corp | Orally administered composition containing antimycotic compounds of triazole |
DE19626924C2 (en) * | 1996-07-04 | 1999-08-19 | Epazon B V | Breathing gas supply device |
SK284813B6 (en) * | 1997-03-26 | 2005-12-01 | Janssen Pharmaceutica N. V. | Pellet comprising itraconazole, method for its preparation and pharmaceutical dosage form comprising thereof |
-
1998
- 1998-07-21 ES ES009801539A patent/ES2157731B1/en not_active Expired - Fee Related
-
1999
- 1999-07-20 UA UA2001021260A patent/UA64009C2/en unknown
- 1999-07-20 DE DE69905905T patent/DE69905905T2/en not_active Expired - Lifetime
- 1999-07-20 AU AU47821/99A patent/AU750730B2/en not_active Ceased
- 1999-07-20 ES ES99931261T patent/ES2194480T3/en not_active Expired - Lifetime
- 1999-07-20 AT AT99931261T patent/ATE234077T1/en active
- 1999-07-20 EE EEP200100041A patent/EE04415B1/en not_active IP Right Cessation
- 1999-07-20 CA CA002337509A patent/CA2337509C/en not_active Expired - Fee Related
- 1999-07-20 SK SK86-2001A patent/SK283279B6/en not_active IP Right Cessation
- 1999-07-20 PL PL99345625A patent/PL194740B1/en not_active IP Right Cessation
- 1999-07-20 PT PT99931261T patent/PT1103252E/en unknown
- 1999-07-20 JP JP2000560874A patent/JP4190732B2/en not_active Expired - Fee Related
- 1999-07-20 IL IL14091099A patent/IL140910A/en not_active IP Right Cessation
- 1999-07-20 EP EP99931261A patent/EP1103252B1/en not_active Expired - Lifetime
- 1999-07-20 KR KR1020017000783A patent/KR100572135B1/en not_active IP Right Cessation
- 1999-07-20 WO PCT/ES1999/000230 patent/WO2000004881A1/en not_active Application Discontinuation
- 1999-07-20 RU RU2001104894/14A patent/RU2209628C2/en not_active IP Right Cessation
- 1999-07-20 HU HU0103708A patent/HU228895B1/en not_active IP Right Cessation
- 1999-07-20 ME MEP-267/08A patent/MEP26708A/en unknown
- 1999-07-20 TR TR2001/00177T patent/TR200100177T2/en unknown
- 1999-07-20 BR BR9912300-2A patent/BR9912300A/en not_active Application Discontinuation
- 1999-07-20 CZ CZ2001175A patent/CZ291938B6/en not_active IP Right Cessation
- 1999-07-20 NZ NZ509886A patent/NZ509886A/en not_active IP Right Cessation
- 1999-07-20 US US09/744,322 patent/US6737082B1/en not_active Expired - Fee Related
- 1999-07-20 RS YUP-39/01A patent/RS50063B/en unknown
- 1999-07-20 MX MXPA01000681A patent/MXPA01000681A/en active IP Right Grant
- 1999-07-20 DK DK99931261T patent/DK1103252T3/en active
-
2001
- 2001-01-17 NO NO20010289A patent/NO320054B1/en not_active IP Right Cessation
- 2001-02-15 ZA ZA200101293A patent/ZA200101293B/en unknown
- 2001-02-21 HR HR20010128A patent/HRP20010128B1/en not_active IP Right Cessation
- 2001-02-21 BG BG105282A patent/BG65187B1/en unknown
- 2001-11-27 HK HK01108330A patent/HK1037531A1/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2157731B1 (en) | ORAL PHARMACEUTICAL PREPARATION OF AN ANTIFUNGIC ACTIVITY COMPOUND AND PROCEDURE FOR PREPARATION. | |
CA2396152A1 (en) | Osmotic device within an osmotic device | |
DK1183014T3 (en) | Flavored controlled release oral pharmaceutical compositions | |
ATE334663T1 (en) | MEDICINAL COMPOSITION WITH DELAYED RELEASE | |
BR9917089A (en) | Compositions and methods for mucosal distribution | |
JP2003512395A5 (en) | ||
CA2322875A1 (en) | A coated chewing gum, a method for preparation thereof and the use of one or more active substance(s) in solid form | |
CA2446712A1 (en) | System for osmotic delivery of pharmaceutically active agents | |
ATE207734T1 (en) | FLUTICASONE PROPIONATE FORMULATIONS | |
NO970361D0 (en) | Sprayable film-forming system that releases active substances for use on plants | |
DE69914320D1 (en) | METHOD FOR PRODUCING A TAPEED DOSE FOR EXTENDED RELEASE OF AN ACTIVE SUBSTANCE | |
ES2535751T3 (en) | Selective herbicides based on heteroaryloxy-acetamides | |
AR033862A1 (en) | MEDICINAL FORMULATION CONTAINING A MUSCARINIC AGONIST AGENT | |
RU2002133953A (en) | METHOD FOR TREATING PATIENTS WITH GENERALIZED PERIODONTITIS | |
UY26503A1 (en) | "DRUG DOSAGE FORM DRIVEN BY A HYDROGEL" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20010816 Kind code of ref document: A1 Effective date: 20010816 |
|
FD1A | Patent lapsed |
Effective date: 20100315 |